Search Results - Holanek, M.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    P004 - Decision impact of the 21-Gene Oncotype DX Recurrence Score Assay® in the Czech Republic on recommendations for adjuvant chemotherapy in estrogen receptor positive early stage breast cancer (ESBC) patients

    P004 - Decision impact of the 21-Gene Oncotype DX Recurrence Score Assay® in the Czech Republic on recommendations for adjuvant chemotherapy in estrogen receptor positive early sta... by Petrakova, K., Petruzelka, L., Holanek, M., Svoboda, T., Benesova, V., Palacova, M., Kolarova, I., Bielcikova, Z., Chrapava, M.

    Published in Breast (Edinburgh)
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Decision impact of the 21-Gene Oncotype DX Recurrence Score Assay® in the Czech Republic on recommendations for adjuvant chemotherapy in estrogen receptor positive early stage breast cancer (ESBC) patients

    Decision impact of the 21-Gene Oncotype DX Recurrence Score Assay® in the Czech Republic on recommendations for adjuvant chemotherapy in estrogen receptor positive early stage brea... by Petrakova, K., Petruzelka, L., Holanek, M., Svoboda, T., Benesova, V., Palacova, M., Kolarova, I., Bielcikova, Z., Chrapava, M.

    Published in Breast (Edinburgh)
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    A185 High Thrombospondin Level Correlates Closely with Poor Response to Bortezomib Treatment

    A185 High Thrombospondin Level Correlates Closely with Poor Response to Bortezomib Treatment by Pour, L, Svachova, H, Nemec, P, Adam, Z, Krejci, M, Sandecka, V, Holanek, M, Kovarova, L, Zahradova, L, Penka, M, Hajek, R

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: